+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Immunoprotein Market by Product, Technology, Application, End User - Global Forecast 2025-2030- Product Image
Immunoprotein Market by Product, Technology, Application, End User - Global Forecast 2025-2030- Product Image
Sale

Immunoprotein Market by Product, Technology, Application, End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 182 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5532790
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The immunoprotein market is navigating a dynamic era as advanced diagnostics and therapeutics transform patient care pathways, driving strategic adjustments for industry leaders globally.

Market Snapshot: Growth Trends in the Immunoprotein Market

The immunoprotein market expanded from USD 21.54 billion in 2024 to USD 23.81 billion in 2025 and is projected to achieve USD 38.72 billion by 2030, growing at a CAGR of 10.26%. This robust trajectory reflects ongoing innovation in immune recognition, biotechnological advancements, and responsive strategies to evolving clinical standards. The sector’s momentum is underpinned by continuous improvements in protein engineering, specificity, and diversified applications spanning therapeutic and diagnostic domains.

Scope & Segmentation

This report delivers a comprehensive analysis of the global immunoprotein market, focusing on technological, application, and regional segmentation to guide actionable decisions. Key areas include:

  • Product Types: Intramuscular immunoglobulin—standard options suited for routine administration; intravenous immunoglobulin—branded, generic, hypoimmune, and next-generation variants for specialized needs; subcutaneous immunoglobulin—conventional and facilitated delivery solutions for improved patient compliance.
  • Technologies: Capillary electrophoresis; enzyme-linked immunosorbent assays; liquid chromatography-mass spectrometry; protein microarrays; and surface plasmon resonance instruments enable advanced analytics and real-time detection.
  • Applications: Diagnostic uses such as disease marker detection, immune response monitoring, and pharmacokinetic evaluations; therapeutic roles addressing autoimmune, hematological, immunodeficiency, infectious, and neurological disorders.
  • End Users: Diagnostic centers; home healthcare services; hospitals; research laboratories; and specialty clinics with distinct operational demands.
  • Regional Markets: Americas (including United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, and others), Asia-Pacific (China, India, Japan, Australia, South Korea, and more).
  • Key Companies: Grifols, Octapharma, Kedrion, Biotest, CSL Limited, Bio Products Laboratory, ADMA Biologics, Eurofins Scientific, Siemens Healthineers, Roche Diagnostics.

Key Takeaways for Decision-Makers

  • Technological integration is redefining immunoprotein analysis, supporting high-throughput and multi-analyte detection for accelerated clinical outcomes.
  • Regulatory environments are becoming more flexible, with adaptive licensing and harmonized quality frameworks supporting cross-border collaborations for therapeutic development.
  • Tailored product formats and delivery systems, especially in subcutaneous and intravenous segments, reflect ongoing efforts to enhance patient-centric care and adherence.
  • Regional dynamics drive distinct adoption patterns, with the Americas emphasizing precision medicine and Asia-Pacific focused on manufacturing scale and rural access.
  • Strategic partnerships, including collaborations between multinational and regional firms, are critical for extending reach and expediting novel immunoprotein solutions to market.
  • Sustainability and supply chain digitization are gaining prominence, shaping investment decisions in manufacturing, packaging, and distribution processes.

Tariff Impact: Navigating US Regulatory Changes and Supply Chain Adjustments

In 2025, the United States introduced revised tariffs affecting antibodies, reagents, and chromatography consumables. These adjustments have increased procurement costs for global stakeholders and required agile responses such as domestic manufacturing partnerships, updated sourcing tactics, and optimized inventory strategies. Healthcare providers and diagnostic laboratories are recalibrating reimbursement models and contract structures to mitigate downstream cost implications. Companies are also leveraging supplier agreements and in-region production to sustain operational resilience within the evolving trade landscape.

Methodology & Data Sources

The report utilizes a blended research model incorporating primary and secondary data. Primary insights were obtained through structured interviews with industry and clinical stakeholders, while secondary data was synthesized from scientific publications, regulatory filings, industry reports, patent records, and clinical databases. Rigorous data triangulation ensures reliability, with key findings validated by expert feedback and cross-verification against financial disclosures and benchmark reports.

Why This Report Matters

  • Enables senior leaders to anticipate market shifts, regulatory trends, and supply chain challenges, ensuring informed, future-proofed strategic planning.
  • Offers granular segmentation and actionable insights to support product portfolio optimization, technology investments, and market entry strategies.
  • Equips organizations to adapt rapidly to evolving competitive, operational, and geopolitical scenarios—heightening business agility and resilience.

Conclusion

The immunoprotein market is poised for sustained evolution, shaped by technology, adaptable regulatory strategies, and regional strengths. Forward-thinking organizations are aligning with these trends to capture growth and secure long-term value as the landscape advances.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Growing adoption of bioengineered immunoglobulin manufacturing platforms to improve yield and consistency in antibody production
5.2. Surge in demand for COVID-19 neutralizing antibody tests fueling expansion of immunoprotein diagnostic portfolios
5.3. Integration of artificial intelligence in immunoprotein reagent design accelerating discovery of novel therapeutic antibodies
5.4. Expansion of point-of-care immunoprotein assays for early detection of infectious diseases in decentralized healthcare settings
5.5. Strategic collaborations between biotech startups and pharmaceutical giants to advance next-generation immunoprotein therapies
5.6. Regulatory approvals of bispecific antibodies setting new benchmarks for complex immunoprotein drug development pipelines
5.7. Increasing investments in single-cell immunoproteomics technologies enabling deeper insights into immune response mechanisms
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Immunoprotein Market, by Product
8.1. Introduction
8.2. Intramuscular Immunoglobulin
8.2.1. Standard
8.3. Intravenous Immunoglobulin
8.3.1. Branded
8.3.2. Generic
8.3.3. Hypoimmune
8.3.4. Next Generation
8.4. Subcutaneous Immunoglobulin
8.4.1. Conventional
8.4.2. Facilitated
9. Immunoprotein Market, by Technology
9.1. Introduction
9.2. Capillary Electrophoresis
9.3. Enzyme Linked Immunosorbent Assay
9.4. Liquid Chromatography Mass Spectrometry
9.5. Protein Microarray
9.6. Surface Plasmon Resonance
10. Immunoprotein Market, by Application
10.1. Introduction
10.2. Diagnostic
10.2.1. Disease Marker Detection
10.2.2. Immune Response Assessment
10.2.3. Pharmacokinetic Studies
10.3. Therapeutic
10.3.1. Autoimmune Disorders
10.3.2. Hematological Disorders
10.3.3. Immunodeficiency Disorders
10.3.4. Infectious Diseases
10.3.5. Neurological Disorders
11. Immunoprotein Market, by End User
11.1. Introduction
11.2. Diagnostic Centers
11.3. Home Healthcare Settings
11.4. Hospitals
11.5. Research Laboratories
11.6. Specialty Clinics
12. Americas Immunoprotein Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Immunoprotein Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Immunoprotein Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Grifols, S.A.
15.3.2. Octapharma AG
15.3.3. Kedrion S.p.A.
15.3.4. Biotest AG
15.3.5. CSL Limited
15.3.6. Bio Products Laboratory Ltd.
15.3.7. ADMA Biologics, Inc.
15.3.8. Eurofins Scientific Limited
15.3.9. Siemens Healthineers AG
15.3.10. Roche Diagnostics International Ltd
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. IMMUNOPROTEIN MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL IMMUNOPROTEIN MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2024 VS 2030 (%)
FIGURE 6. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 8. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS IMMUNOPROTEIN MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS IMMUNOPROTEIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES IMMUNOPROTEIN MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES IMMUNOPROTEIN MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA IMMUNOPROTEIN MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA IMMUNOPROTEIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC IMMUNOPROTEIN MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC IMMUNOPROTEIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. IMMUNOPROTEIN MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. IMMUNOPROTEIN MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. IMMUNOPROTEIN MARKET: RESEARCHAI
FIGURE 24. IMMUNOPROTEIN MARKET: RESEARCHSTATISTICS
FIGURE 25. IMMUNOPROTEIN MARKET: RESEARCHCONTACTS
FIGURE 26. IMMUNOPROTEIN MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. IMMUNOPROTEIN MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL IMMUNOPROTEIN MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL IMMUNOPROTEIN MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY INTRAMUSCULAR IMMUNOGLOBULIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY INTRAMUSCULAR IMMUNOGLOBULIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY STANDARD, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY STANDARD, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY INTRAMUSCULAR IMMUNOGLOBULIN, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY INTRAMUSCULAR IMMUNOGLOBULIN, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY INTRAVENOUS IMMUNOGLOBULIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY INTRAVENOUS IMMUNOGLOBULIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY BRANDED, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY BRANDED, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY GENERIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY GENERIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY HYPOIMMUNE, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY HYPOIMMUNE, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY NEXT GENERATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY NEXT GENERATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY INTRAVENOUS IMMUNOGLOBULIN, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY INTRAVENOUS IMMUNOGLOBULIN, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY SUBCUTANEOUS IMMUNOGLOBULIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY SUBCUTANEOUS IMMUNOGLOBULIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY CONVENTIONAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY CONVENTIONAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY FACILITATED, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY FACILITATED, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY SUBCUTANEOUS IMMUNOGLOBULIN, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY SUBCUTANEOUS IMMUNOGLOBULIN, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY CAPILLARY ELECTROPHORESIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY CAPILLARY ELECTROPHORESIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY LIQUID CHROMATOGRAPHY MASS SPECTROMETRY, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY LIQUID CHROMATOGRAPHY MASS SPECTROMETRY, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY PROTEIN MICROARRAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY PROTEIN MICROARRAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY SURFACE PLASMON RESONANCE, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY SURFACE PLASMON RESONANCE, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY DIAGNOSTIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY DIAGNOSTIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY DISEASE MARKER DETECTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY DISEASE MARKER DETECTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY IMMUNE RESPONSE ASSESSMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY IMMUNE RESPONSE ASSESSMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY PHARMACOKINETIC STUDIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY PHARMACOKINETIC STUDIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY DIAGNOSTIC, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY DIAGNOSTIC, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY THERAPEUTIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY THERAPEUTIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY HEMATOLOGICAL DISORDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY HEMATOLOGICAL DISORDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY IMMUNODEFICIENCY DISORDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY IMMUNODEFICIENCY DISORDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY THERAPEUTIC, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY THERAPEUTIC, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY HOME HEALTHCARE SETTINGS, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY HOME HEALTHCARE SETTINGS, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL IMMUNOPROTEIN MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS IMMUNOPROTEIN MARKET SIZE, BY INTRAMUSCULAR IMMUNOGLOBULIN, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS IMMUNOPROTEIN MARKET SIZE, BY INTRAMUSCULAR IMMUNOGLOBULIN, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS IMMUNOPROTEIN MARKET SIZE, BY INTRAVENOUS IMMUNOGLOBULIN, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS IMMUNOPROTEIN MARKET SIZE, BY INTRAVENOUS IMMUNOGLOBULIN, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS IMMUNOPROTEIN MARKET SIZE, BY SUBCUTANEOUS IMMUNOGLOBULIN, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS IMMUNOPROTEIN MARKET SIZE, BY SUBCUTANEOUS IMMUNOGLOBULIN, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS IMMUNOPROTEIN MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS IMMUNOPROTEIN MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS IMMUNOPROTEIN MARKET SIZE, BY DIAGNOSTIC, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS IMMUNOPROTEIN MARKET SIZE, BY DIAGNOSTIC, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS IMMUNOPROTEIN MARKET SIZE, BY THERAPEUTIC, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS IMMUNOPROTEIN MARKET SIZE, BY THERAPEUTIC, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS IMMUNOPROTEIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS IMMUNOPROTEIN MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS IMMUNOPROTEIN MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 107. UNITED STATES IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 108. UNITED STATES IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 109. UNITED STATES IMMUNOPROTEIN MARKET SIZE, BY INTRAMUSCULAR IMMUNOGLOBULIN, 2018-2024 (USD MILLION)
TABLE 110. UNITED STATES IMMUNOPROTEIN MARKET SIZE, BY INTRAMUSCULAR IMMUNOGLOBULIN, 2025-2030 (USD MILLION)
TABLE 111. UNITED STATES IMMUNOPROTEIN MARKET SIZE, BY INTRAVENOUS IMMUNOGLOBULIN, 2018-2024 (USD MILLION)
TABLE 112. UNITED STATES IMMUNOPROTEIN MARKET SIZE, BY INTRAVENOUS IMMUNOGLOBULIN, 2025-2030 (USD MILLION)
TABLE 113. UNITED STATES IMMUNOPROTEIN MARKET SIZE, BY SUBCUTANEOUS IMMUNOGLOBULIN, 2018-2024 (USD MILLION)
TABLE 114. UNITED STATES IMMUNOPROTEIN MARKET SIZE, BY SUBCUTANEOUS IMMUNOGLOBULIN, 2025-2030 (USD MILLION)
TABLE 115. UNITED STATES IMMUNOPROTEIN MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 116. UNITED STATES IMMUNOPROTEIN MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 117. UNITED STATES IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 118. UNITED STATES IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 119. UNITED STATES IMMUNOPROTEIN MARKET SIZE, BY DIAGNOSTIC, 2018-2024 (USD MILLION)
TABLE 120. UNITED STATES IMMUNOPROTEIN MARKET SIZE, BY DIAGNOSTIC, 2025-2030 (USD MILLION)
TABLE 121. UNITED STATES IMMUNOPROTEIN MARKET SIZE, BY THERAPEUTIC, 2018-2024 (USD MILLION)
TABLE 122. UNITED STATES IMMUNOPROTEIN MARKET SIZE, BY THERAPEUTIC, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES IMMUNOPROTEIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES IMMUNOPROTEIN MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES IMMUNOPROTEIN MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 127. CANADA IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 128. CANADA IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 129. CANADA IMMUNOPROTEIN MARKET SIZE, BY INTRAMUSCULAR IMMUNOGLOBULIN, 2018-2024 (USD MILLION)
TABLE 130. CANADA IMMUNOPROTEIN MARKET SIZE, BY INTRAMUSCULAR IMMUNOGLOBULIN, 2025-2030 (USD MILLION)
TABLE 131. CANADA IMMUNOPROTEIN MARKET SIZE, BY INTRAVENOUS IMMUNOGLOBULIN, 2018-2024 (USD MILLION)
TABLE 132. CANADA IMMUNOPROTEIN MARKET SIZE, BY INTRAVENOUS IMMUNOGLOBULIN, 2025-2030 (USD MILLION)
TABLE 133. CANADA IMMUNOPROTEIN MARKET SIZE, BY SUBCUTANEOUS IMMUNOGLOBULIN, 2018-2024 (USD MILLION)
TABLE 134. CANADA IMMUNOPROTEIN MARKET SIZE, BY SUBCUTANEOUS IMMUNOGLOBULIN, 2025-2030 (USD MILLION)
TABLE 135. CANADA IMMUNOPROTEIN MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 136. CANADA IMMUNOPROTEIN MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 137. CANADA IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 138. CANADA IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 139. CANADA IMMUNOPROTEIN MARKET SIZE, BY DIAGNOSTIC, 2018-2024 (USD MILLION)
TABLE 140. CANADA IMMUNOPROTEIN MARKET SIZE, BY DIAGNOSTIC, 2025-2030 (USD MILLION)
TABLE 141. CANADA IMMUNOPROTEIN MARKET SIZE, BY THERAPEUTIC, 2018-2024 (USD MILLION)
TABLE 142. CANADA IMMUNOPROTEIN MARKET SIZE, BY THERAPEUTIC, 2025-2030 (USD MILLION)
TABLE 143. CANADA IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 144. CANADA IMMUNOPROTEIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 145. MEXICO IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 146. MEXICO IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 147. MEXICO IMMUNOPROTEIN MARKET SIZE, BY INTRAMUSCULAR IMMUNOGLOBULIN, 2018-2024 (USD MILLION)
TABLE 148. MEXICO IMMUNOPROTEIN MARKET SIZE, BY INTRAMUSCULAR IMMUNOGLOBULIN, 2025-2030 (USD MILLION)
TABLE 149. MEXICO IMMUNOPROTEIN MARKET SIZE, BY INTRAVENOUS IMMUNOGLOBULIN, 2018-2024 (USD MILLION)
TABLE 150. MEXICO IMMUNOPROTEIN MARKET SIZE, BY INTRAVENOUS IMMUNOGLOBULIN, 2025-2030 (USD MILLION)
TABLE 151. MEXICO IMMUNOPROTEIN MARKET SIZE, BY SUBCUTANEOUS IMMUNOGLOBULIN, 2018-2024 (USD MILLION)
TABLE 152. MEXICO IMMUNOPROTEIN MARKET SIZE, BY SUBCUTANEOUS IMMUNOGLOBULIN, 2025-2030 (USD MILLION)
TABLE 153. MEXICO IMMUNOPROTEIN MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 154. MEXICO IMMUNOPROTEIN MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 155. MEXICO IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 156. MEXICO IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 157. MEXICO IMMUNOPROTEIN MARKET SIZE, BY DIAGNOSTIC, 2018-2024 (USD MILLION)
TABLE 158. MEXICO IMMUNOPROTEIN MARKET SIZE, BY DIAGNOSTIC, 2025-2030 (USD MILLION)
TABLE 159. MEXICO IMMUNOPROTEIN MARKET SIZE, BY THERAPEUTIC, 2018-2024 (USD MILLION)
TABLE 160. MEXICO IMMUNOPROTEIN MARKET SIZE, BY THERAPEUTIC, 2025-2030 (USD MILLION)
TABLE 161. MEXICO IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 162. MEXICO IMMUNOPROTEIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 163. BRAZIL IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 164. BRAZIL IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 165. BRAZIL IMMUNOPROTEIN MARKET SIZE, BY INTRAMUSCULAR IMMUNOGLOBULIN, 2018-2024 (USD MILLION)
TABLE 166. BRAZIL IMMUNOPROTEIN MARKET SIZE, BY INTRAMUSCULAR IMMUNOGLOBULIN, 2025-2030 (USD MILLION)
TABLE 167. BRAZIL IMMUNOPROTEIN MARKET SIZE, BY INTRAVENOUS IMMUNOGLOBULIN, 2018-2024 (USD MILLION)
TABLE 168. BRAZIL IMMUNOPROTEIN MARKET SIZE, BY INTRAVENOUS IMMUNOGLOBULIN, 2025-2030 (USD MILLION)
TABLE 169. BRAZIL IMMUNOPROTEIN MARKET SIZE, BY SUBCUTANEOUS IMMUNOGLOBULIN, 2018-2024 (USD MILLION)
TABLE 170. BRAZIL IMMUNOPROTEIN MARKET SIZE, BY SUBCUTANEOUS IMMUNOGLOBULIN, 2025-2030 (USD MILLION)
TABLE 171. BRAZIL IMMUNOPROTEIN MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 172. BRAZIL IMMUNOPROTEIN MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 173. BRAZIL IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 174. BRAZIL IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 175. BRAZIL IMMUNOPROTEIN MARKET SIZE, BY DIAGNOSTIC, 2018-2024 (USD MILLION)
TABLE 176. BRAZIL IMMUNOPROTEIN MARKET SIZE, BY DIAGNOSTIC, 2025-2030 (USD MILLION)
TABLE 177. BRAZIL IMMUNOPROTEIN MARKET SIZE, BY THERAPEUTIC, 2018-2024 (USD MILLION)
TABLE 178. BRAZIL IMMUNOPROTEIN MARKET SIZE, BY THERAPEUTIC, 2025-2030 (USD MILLION)
TABLE 179. BRAZIL IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 180. BRAZIL IMMUNOPROTEIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 181. ARGENTINA IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 182. ARGENTINA IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 183. ARGENTINA IMMUNOPROTEIN MARKET SIZE, BY INTRAMUSCULAR IMMUNOGLOBULIN, 2018-2024 (USD MILLION)
TABLE 184. ARGENTINA IMMUNOPROTEIN MARKET SIZE, BY INTRAMUSCULAR IMMUNOGLOBULIN, 2025-2030 (USD MILLION)
TABLE 185. ARGENTINA IMMUNOPROTEIN MARKET SIZE, BY INTRAVENOUS IMMUNOGLOBULIN, 2018-2024 (USD MILLION)
TABLE 186. ARGENTINA IMMUNOPROTEIN MARKET SIZE, BY INTRAVENOUS IMMUNOGLOBULIN, 2025-2030 (USD MILLION)
TABLE 187. ARGENTINA IMMUNOPROTEIN MARKET SIZE, BY SUBCUTANEOUS IMMUNOGLOBULIN, 2018-2024 (USD MILLION)
TABLE 188. ARGENTINA IMMUNOPROTEIN MARKET SIZE, BY SUBCUTANEOUS IMMUNOGLOBULIN, 2025-2030 (USD MILLION)
TABLE 189. ARGENTINA IMMUNOPROTEIN MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 190. ARGENTINA IMMUNOPROTEIN MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 191. ARGENTINA IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 192. ARGENTINA IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 193. ARGENTINA IMMUNOPROTEIN MARKET SIZE, BY DIAGNOSTIC, 2018-2024 (USD MILLION)
TABLE 194. ARGENTINA IMMUNOPROTEIN MARKET SIZE, BY DIAGNOSTIC, 2025-2030 (USD MILLION)
TABLE 195. ARGENTINA IMMUNOPROTEIN MARKET SIZE, BY THERAPEUTIC, 2018-2024 (USD MILLION)
TABLE 196. ARGENTINA IMMUNOPROTEIN MARKET SIZE, BY THERAPEUTIC, 2025-2030 (USD MILLION)
TABLE 197. ARGENTINA IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 198. ARGENTINA IMMUNOPROTEIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 199. EUROPE, MIDDLE EAST & AFRICA IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 200. EUROPE, MIDDLE EAST & AFRICA IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 201. EUROPE, MIDDLE EAST & AFRICA IMMUNOPROTEIN MARKET SIZE, BY INTRAMUSCULAR IMMUNOGLOBULIN, 2018-2024 (USD MILLION)
TABLE 202. EUROPE, MIDDLE EAST & AFRICA IMMUNOPROTEIN MARKET SIZE, BY INTRAMUSCULAR IMMUNOGLOBULIN, 2025-2030 (USD MILLION)
TABLE 203. EUROPE, MIDDLE EAST & AFRICA IMMUNOPROTEIN MARKET SIZE, BY INTRAVENOUS IMMUNOGLOBULIN, 2018-2024 (USD MILLION)
TABLE 204. EUROPE, MIDDLE EAST & AFRICA IMMUNOPROTEIN MARKET SIZE, BY INTRAVENOUS IMMUNOGLOBULIN, 2025-2030 (USD MILLION)
TABLE 205. EUROPE, MIDDLE EAST & AFRICA IMMUNOPROTEIN MARKET SIZE, BY SUBCUTANEOUS IMMUNOGLOBULIN, 2018-2024 (USD MILLION)
TABLE 206. EUROPE, MIDDLE EAST & AFRICA IMMUNOPROTEIN MARKET SIZE, BY SUBCUTANEOUS IMMUNOGLOBULIN, 2025-2030 (USD MILLION)
TABLE 207. EUROPE, MIDDLE EAST & AFRICA IMMUNOPROTEIN MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 208. EUROPE, MIDDLE EAST & AFRICA IMMUNOPROTEIN MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 209. EUROPE, MIDDLE EAST & AFRICA IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 210. EUROPE, MIDDLE EAST & AFRICA IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 211. EUROPE, MIDDLE EAST & AFRICA IMMUNOPROTEIN MARKET SIZE, BY DIAGNOSTIC, 2018-2024 (USD MILLION)
TABLE 212. EUROPE, MIDDLE EAST & AFRICA IMMUNOPROTEIN MARKET SIZE, BY DIAGNOSTIC, 2025-2030 (USD MILLION)
TABLE 213. EUROPE, MIDDLE EAST & AFRICA IMMUNOPROTEIN MARKET SIZE, BY THERAPEUTIC, 2018-2024 (USD MILLION)
TABLE 214. EUROPE, MIDDLE EAST & AFRICA IMMUNOPROTEIN MARKET SIZE, BY THERAPEUTIC, 2025-2030 (USD MILLION)
TABLE 215. EUROPE, MIDDLE EAST & AFRICA IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 216. EUROPE, MIDDLE EAST & AFRICA IMMUNOPROTEIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 217. EUROPE, MIDDLE EAST & AFRICA IMMUNOPROTEIN MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 218. EUROPE, MIDDLE EAST & AFRICA IMMUNOPROTEIN MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 219. UNITED KINGDOM IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 220. UNITED KINGDOM IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 221. UNITED KINGDOM IMMUNOPROTEIN MARKET SIZE, BY INTRAMUSCULAR IMMUNOGLOBULIN, 2018-2024 (USD MILLION)
TABLE 222. UNITED KINGDOM IMMUNOPROTEIN MARKET SIZE, BY INTRAMUSCULAR IMMUNOGLOBULIN, 2025-2030 (USD MILLION)
TABLE 223. UNITED KINGDOM IMMUNOPROTEIN MARKET SIZE, BY INTRAVENOUS IMMUNOGLOBULIN, 2018-2024 (USD MILLION)
TABLE 224. UNITED KINGDOM IMMUNOPROTEIN MARKET SIZE, BY INTRAVENOUS IMMUNOGLOBULIN, 2025-2030 (USD MILLION)
TABLE 225. UNITED KINGDOM IMMUNOPROTEIN MARKET SIZE, BY SUBCUTANEOUS IMMUNOGLOBULIN, 2018-2024 (USD MILLION)
TABLE 226. UNITED KINGDOM IMMUNOPROTEIN MARKET SIZE, BY SUBCUTANEOUS IMMUNOGLOBULIN, 2025-2030 (USD MILLION)
TABLE 227. UNITED KINGDOM IMMUNOPROTEIN MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 228. UNITED KINGDOM IMMUNOPROTEIN MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 229. UNITED KINGDOM IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 230. UNITED KINGDOM IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 231. UNITED KINGDOM IMMUNOPROTEIN MARKET SIZE, BY DIAGNOSTIC, 2018-2024 (USD MILLION)
TABLE 232. UNITED KINGDOM IMMUNOPROTEIN MARKET SIZE, BY DIAGNOSTIC, 2025-2030 (USD MILLION)
TABLE 233. UNITED KINGDOM IMMUNOPROTEIN MARKET SIZE, BY THERAPEUTIC, 2018-2024 (USD MILLION)
TABLE 234. UNITED KINGDOM IMMUNOPROTEIN MARKET SIZE, BY THERAPEUTIC, 2025-2030 (USD MILLION)
TABLE 235. UNITED KINGDOM IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 236. UNITED KINGDOM IMMUNOPROTEIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 237. GERMANY IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 238. GERMANY IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 239. GERMANY IMMUNOPROTEIN MARKET SIZE, BY INTRAMUSCULAR IMMUNOGLOBULIN, 2018-2024 (USD MILLION)
TABLE 240. GERMANY IMMUNOPROTEIN MARKET SIZE, BY INTRAMUSCULAR IMMUNOGLOBULIN, 2025-2030 (USD MILLION)
TABLE 241. GERMANY IMMUNOPROTEIN MARKET SIZE, BY INTRAVENOUS IMMUNOGLOBULIN, 2018-2024 (USD MILLION)
TABLE 242. GERMANY IMMUNOPROTEIN MARKET SIZE, BY INTRAVENOUS IMMUNOGLOBULIN, 2025-2030 (USD MILLION)
TABLE 243. GERMANY IMMUNOPROTEIN MARKET SIZE, BY SUBCUTANEOUS IMMUNOGLOBULIN, 2018-2024 (USD MILLION)
TABLE 244. GERMANY IMMUNOPROTEIN MARKET SIZE, BY SUBCUTANEOUS IMMUNOGLOBULIN, 2025-2030 (USD MILLION)
TABLE 245. GERMANY IMMUNOPROTEIN MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 246. GERMANY IMMUNOPROTEIN MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 247. GERMANY IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 248. GERMANY IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 249. GERMANY IMMUNOPROTEIN MARKET SIZE, BY DIAGNOSTIC, 2018-2024 (USD MILLION)
TABLE 250. GERMANY IMMUNOPROTEIN MARKET SIZE, BY DIAGNOSTIC, 2025-2030 (USD MILLION)
TABLE 251. GERMANY IMMUNOPROTEIN MARKET SIZE, BY THERAPEUTIC, 2018-2024 (USD MILLION)
TABLE 252. GERMANY IMMUNOPROTEIN MARKET SIZE, BY THERAPEUTIC, 2025-2030 (USD MILLION)
TABLE 253. GERMANY IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 254. GERMANY IMMUNOPROTEIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 255. FRANCE IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 256. FRANCE IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 257. FRANCE IMMUNOPROTEIN MARKET SIZE, BY INTRAMUSCULAR IMMUNOGLOBULIN, 2018-2024 (USD MILLION)
TABLE 258. FRANCE IMMUNOPROTEIN MARKET SIZE, BY INTRAMUSCULAR IMMUNOGLOBULIN, 2025-2030 (USD MILLION)
TABLE 259. FRANCE IMMUNOPROTEIN MARKET SIZE, BY INTRAVENOUS IMMUNOGLOBULIN, 2018-2024 (USD MILLION)
TABLE 260. FRANCE IMMUNOPROTEIN MARKET SIZE, BY INTRAVENOUS IMMUNOGLOBULIN, 2025-2030 (USD MILLION)
TABLE 261. FRANCE IMMUNOPROTEIN MARKET SIZE, BY SUBCUTANEOUS IMMUNOGLOBULIN, 2018-2024 (USD MILLION)
TABLE 262. FRANCE IMMUNOPROTEIN MARKET SIZE, BY SUBCUTANEOUS IMMUNOGLOBULIN, 2025-2030 (USD MILLION)
TABLE 263. FRANCE IMMUNOPROTEIN MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 264. FRANCE IMMUNOPROTEIN MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 265. FRANCE IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 266. FRANCE IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 267. FRANCE IMMUNOPROTEIN MARKET SIZE, BY DIAGNOSTIC, 2018-2024 (USD MILLION)
TABLE 268. FRANCE IMMUNOPROTEIN MARKET SIZE, BY DIAGNOSTIC, 2025-2030 (USD MILLION)
TABLE 269. FRANCE IMMUNOPROTEIN MARKET SIZE, BY THERAPEUTIC, 2018-2024 (USD MILLION)
TABLE 270. FRANCE IMMUNOPROTEIN MARKET SIZE, BY THERAPEUTIC, 2025-2030 (USD MILLION)
TABLE 271. FRANCE IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 272. FRANCE IMMUNOPROTEIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 273. RUSSIA IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 274. RUSSIA IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 275. RUSSIA IMMUNOPROTEIN MARKET SIZE, BY INTRAMUSCULAR IMMUNOGLOBULIN, 2018-2024 (USD MILLION)
TABLE 276. RUSSIA IMMUNOPROTEIN MARKET SIZE, BY INTRAMUSCULAR IMMUNOGLOBULIN, 2025-2030 (USD MILLION)
TABLE 277. RUSSIA IMMUNOPROTEIN MARKET SIZE, BY INTRAVENOUS IMMUNOGLOBULIN, 2018-2024 (USD MILLION)
TABLE 278. RUSSIA IMMUNOPROTEIN MARKET SIZE, BY INTRAVENOUS IMMUNOGLOBULIN, 2025-2030 (USD MILLION)
TABLE 279. RUSSIA IMMUNOPROTEIN MARKET SIZE, BY SUBCUTANEOUS IMMUNOGLOBULIN, 2018-2024 (USD MILLION)
TABLE 280. RUSSIA IMMUNOPROTEIN MARKET SIZE, BY SUBCUTANEOUS IMMUNOGLOBULIN, 2025-2030 (USD MILLION)
TABLE 281. RUSSIA IMMUNOPROTEIN MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 282. RUSSIA IMMUNOPROTEIN MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 283. RUSSIA IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 284. RUSSIA IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 285. RUSSIA IMMUNOPROTEIN MARKET SIZE, BY DIAGNOSTIC, 2018-2024 (USD MILLION)
TABLE 286. RUSSIA IMMUNOPROTEIN MARKET SIZE, BY DIAGNOSTIC, 2025-2030 (USD MILLION)
TABLE 287. RUSSIA IMMUNOPROTEIN MARKET SIZE, BY THERAPEUTIC, 2018-2024 (USD MILLION)
TABLE 288. RUSSIA IMMUNOPROTEIN MARKET SIZE, BY THERAPEUTIC, 2025-2030 (USD MILLION)
TABLE 289. RUSSIA IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 290. RUSSIA IMMUNOPROTEIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 291. ITALY IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 292. ITALY IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 293. ITALY IMMUNOPROTEIN MARKET SIZE, BY INTRAMUSCULAR IMMUNOGLOBULIN, 2018-2024 (USD MILLION)
TABLE 294. ITALY IMMUNOPROTEIN MARKET SIZE, BY INTRAMUSCULAR IMMUNOGLOBULIN, 2025-2030 (USD MILLION)
TABLE 295. ITALY IMMUNOPROTEIN MARKET SIZE, BY INTRAVENOUS IMMUNOGLOBULIN, 2018-2024 (USD MILLION)
TABLE 296. ITALY IMMUNOPROTEIN MARKET SIZE, BY INTRAVENOUS IMMUNOGLOBULIN, 2025-2030 (USD MILLION)
TABLE 297. ITALY IMMUNOPROTEIN MARKET SIZE, BY SUBCUTANEOUS IMMUNOGLOBULIN, 2018-2024 (USD MILLION)
TABLE 298. ITALY IMMUNOPROTEIN MARKET SIZE, BY SUBCUTANEOUS IMMUNOGLOBULIN, 2025-2030 (USD MILLION)
TABLE 299. ITALY IMMUNOPROTEIN MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 300. ITALY IMMUNOPROTEIN MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 301. ITALY IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 302. ITALY IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 303. ITALY IMMUNOPROTEIN MARKET SIZE, BY DIAGNOSTIC, 2018-2024 (USD MILLION)
TABLE 304. ITALY IMMUNOPROTEIN MARKET SIZE, BY DIAGNOSTIC, 2025-2030 (USD MILLION)
TABLE 305. ITALY IMMUNOPROTEIN MARKET SIZE, BY THERAPEUTIC, 2018-2024 (USD MILLION)
TABLE 306. ITALY IMMUNOPROTEIN MARKET SIZE, BY THERAPEUTIC, 2025-2030 (USD MILLION)
TABLE 307. ITALY IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 308. ITALY IMMUNOPROTEIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 309. SPAIN IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 310. SPAIN IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 311. SPAIN IMMUNOPROTEIN MARKET SIZE, BY INTRAMUSCULAR IMMUNOGLOBULIN, 2018-2024 (USD MILLION)
TABLE 312. SPAIN IMMUNOPROTEIN MARKET SIZE, BY INTRAMUSCULAR IMMUNOGLOBULIN, 2025-2030 (USD MILLION)
TABLE 313. SPAIN IMMUNOPROTEIN MARKET SIZE, BY INTRAVENOUS IMMUNOGLOBULIN, 2018-2024 (USD MILLION)
TABLE 314. SPAIN IMMUNOPROTEIN MARKET SIZE, BY INTRAVENOUS IMMUNOGLOBULIN, 2025-2030 (USD MILLION)
TABLE 315. SPAIN IMMUNOPROTEIN MARKET SIZE, BY SUBCUTANEOUS IMMUNOGLOBULIN, 2018-2024 (USD MILLION)
TABLE 316. SPAIN IMMUNOPROTEIN MARKET SIZE, BY SUBCUTANEOUS IMMUNOGLOBULIN, 2025-2030 (USD MILLION)
TABLE 317. SPAIN IMMUNOPROTEIN MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 318. SPAIN IMMUNOPROTEIN MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 319. SPAIN IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 320. SPAIN IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 321. SPAIN IMMUNOPROTEIN MARKET SIZE, BY DIAGNOSTIC, 2018-2024 (USD MILLION)
TABLE 322. SPAIN IMMUNOPROTEIN MARKET SIZE, BY DIAGNOSTIC, 2025-2030 (USD MILLION)
TABLE 323. SPAIN IMMUNOPROTEIN MARKET SIZE, BY THERAPEUTIC, 2018-2024 (USD MILLION)
TABLE 324. SPAIN IMMUNOPROTEIN MARKET SIZE, BY THERAPEUTIC, 2025-2030 (USD MILLION)
TABLE 325. SPAIN IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 326. SPAIN IMMUNOPROTEIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 327. UNITED ARAB EMIRATES IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 328. UNITED ARAB EMIRATES IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 329. UNITED ARAB EMIRATES IMMUNOPROTEIN MARKET SIZE, BY INTRAMUSCULAR IMMUNOGLOBULIN, 2018-2024 (USD MILLION)
TABLE 330. UNITED ARAB EMIRATES IMMUNOPROTEIN MARKET SIZE, BY INTRAMUSCULAR IMMUNOGLOBULIN, 2025-2030 (USD MILLION)
TABLE 331. UNITED ARAB EMIRATES IMMUNOPROTEIN MARKET SIZE, BY INTRAVENOUS IMMUNOGLOBULIN, 2018-2024 (USD MILLION)
TABLE 332. UNITED ARAB EMIRATES IMMUNOPROTEIN MARKET SIZE, BY INTRAVENOUS IMMUNOGLOBULIN, 2025-2030 (USD MILLION)
TABLE 333. UNITED ARAB EMIRATES IMMUNOPROTEIN MARKET SIZE, BY SUBCUTANEOUS IMMUNOGLOBULIN, 2018-2024 (USD MILLION)
TABLE 334. UNITED ARAB EMIRATES IMMUNOPROTEIN MARKET SIZE, BY SUBCUTANEOUS IMMUNOGLOBULIN, 2025-2030 (USD MILLION)
TABLE 335. UNITED ARAB EMIRATES IMMUNOPROTEIN MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 336. UNITED ARAB EMIRATES IMMUNOPROTEIN MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 337. UNITED ARAB EMIRATES IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 338. UNITED ARAB EMIRATES IMMUNOPROTEIN MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 339. UNITED ARAB EMIRATES IMMUNOPROTEIN MARKET SIZE, BY DIAGNOSTIC, 2018-2024 (USD MILLION)
TABLE 340. UNITED ARAB EMIRATES IMMUNOPROTEIN MARKET SIZE, BY DIAGNOSTIC, 2025-2030 (USD MILLION)
TABLE 341. UNITED ARAB EMIRATES IMMUNOPROTEIN MARKET SIZE, BY THERAPEUTIC, 2018-2024 (USD MILLION)
TABLE 342. UNITED ARAB EMIRATES IMMUNOPROTEIN MARKET SIZE, BY THERAPEUTIC, 2025-2030 (USD MILLION)
TABLE 343. UNITED ARAB EMIRATES IMMUNOPROTEIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 344. UNITED ARAB EMIRATES IMMUNOPROTEIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 345. SAUDI ARABIA IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 346. SAUDI ARABIA IMMUNOPROTEIN MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 347. SAUDI ARABIA IMMUNOPROTEIN MARKET SIZE, BY INTRAMUSCULAR IMMUNOGLOBULIN, 2018-2024 (USD MILLION)
TABLE 348. SAUDI ARABIA IMMUNOPROTEIN MARKET SIZE, BY INTRAMUSCULAR IMMUNOGLOBULIN, 2025-2030 (U

Samples

Loading
LOADING...

Companies Mentioned

  • Grifols, S.A.
  • Octapharma AG
  • Kedrion S.p.A.
  • Biotest AG
  • CSL Limited
  • Bio Products Laboratory Ltd.
  • ADMA Biologics, Inc.
  • Eurofins Scientific Limited
  • Siemens Healthineers AG
  • Roche Diagnostics International Ltd

Table Information

Report AttributeDetails
No. of Pages182
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 23.81 Billion
Forecasted Market Value ( USD ) by 2030 $ 38.72 Billion
Compound Annual Growth Rate10.2%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Immunoprotein Diagnostic Testing Market Size, Share & Trends Analysis Report By Test (Immunoglobulin Diagnostic Tests), By Technology, By Application, By Distribution Channel, By End-use, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Immunoprotein Diagnostic Testing Market Size, Share & Trends Analysis Report By Test (Immunoglobulin Diagnostic Tests), By Technology, By Application, By Distribution Channel, By End-use, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 180 Pages
  • Global
From
Immunoprotein Diagnostic Testing Market by Assay Type (Antibody Test, Antigen Test, Autoantibody Test), Technology (Clia, Elisa, Fluorescence Polarization Immunoassay), End User, Application, Sample Type - Global Forecast 2025-2030 - Product Image

Immunoprotein Diagnostic Testing Market by Assay Type (Antibody Test, Antigen Test, Autoantibody Test), Technology (Clia, Elisa, Fluorescence Polarization Immunoassay), End User, Application, Sample Type - Global Forecast 2025-2030

  • Report
  • 199 Pages
  • Global
From
Immunoprotein Diagnostic Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Immunoprotein Diagnostic Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 182 Pages
  • Global
From
Immunoprotein Diagnostic Testing - Global Strategic Business Report - Product Image

Immunoprotein Diagnostic Testing - Global Strategic Business Report

  • Report
  • 171 Pages
  • Global
From
2025 Global Immunodiagnostics Market Database for the US, Europe, Japan-2024 Supplier Shares, 2024-2029 Volume and Sales Segment Forecasts for 130 Abused Drugs, Cancer, Clinical Chemistry, Endocrine, Immunoprotein and TDM Tests - Product Image

2025 Global Immunodiagnostics Market Database for the US, Europe, Japan-2024 Supplier Shares, 2024-2029 Volume and Sales Segment Forecasts for 130 Abused Drugs, Cancer, Clinical Chemistry, Endocrine, Immunoprotein and TDM Tests

  • Report
  • Europe, Global, United States Europe, Global, United States
From

About the Immunoprotein Market

The Immunoprotein market within the In Vitro Diagnostics (IVD) industry is a rapidly growing sector. It is used to detect and measure the presence of antigens and antibodies in a patient's sample. Immunoprotein tests are used to diagnose a variety of conditions, including autoimmune diseases, allergies, infections, and cancer. These tests are also used to monitor the effectiveness of treatments. Immunoprotein tests are typically performed in a laboratory setting, and the results are used to inform clinical decisions. The tests are highly sensitive and specific, and they can be used to detect even small amounts of antigens or antibodies. The Immunoprotein market is expected to continue to grow as more tests become available and as the demand for IVD tests increases. This growth is driven by the increasing prevalence of chronic diseases, the need for more accurate and timely diagnosis, and the development of new technologies. Some of the major players in the Immunoprotein market include Abbott Laboratories, Bio-Rad Laboratories, Siemens Healthineers, Roche Diagnostics, and Thermo Fisher Scientific. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.